C12Y 108/04
Oxidoreductases acting on sulfur groups as donors: with a disulfide as acceptor
Official title: with a disulfide as acceptor (1.8.4)
C12Y108/04 (Oxidoreductases acting on sulfur groups as donors: with a disulfide as acceptor) appears on 19 US grants and 33 published applications in this corpus.
Search patents in C12Y- Granted patents
- 19
- Published applications
- 33
- Assignees
- 27
- Inventors
- 65
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 1 | 1 |
| 2015 | 2 | 3 |
| 2016 | 1 | 5 |
| 2017 | 0 | 3 |
| 2018 | 3 | 1 |
| 2019 | 2 | 4 |
| 2020 | 2 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 3 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 108/0401Adenylyl-sulfate reductase8
- C12Y 108/04005Methionine-s-oxide reductase3
- C12Y 108/04011Peptide-methionine -s-oxide reductase3
- C12Y 108/04002Protein-disulfide reductase , i.e. bdbc or bdbd2
- C12Y 108/04008Phosphoadenylyl-sulfate reductase2
- C12Y 108/04012Peptide-methionine -s-oxide reductase1
- C12Y 108/04013L-methionine -s-oxide reductase1
- C12Y 108/04014L-methionine -s-oxide reductase1
Recent patents
- Biocatalyst as a core component of an enzyme-catalyzed redox system for the biocatalytic reduction of cystine14 Apr 2026US 12,600,995 B2Wacker Chemie AG
- Product and process for mucus viscosity normalization19 Aug 2025US 12,390,511 B2Orpro Therapeutics, Inc.
- Redox-based reagents for methionine bioconjugation7 Jun 2022US 11,353,463 B2The Regents of the University of California
- Polynucleotides encoding BREX system polypeptides and methods of using same8 Sep 2020US 10,767,156 B2Yeda Research and Development Co. Ltd.
- Ultrapurified DsbA and DsbC and methods of making and using the same23 Jun 2020US 10,690,671 B2Genentech, Inc.
- Product and process for mucus viscosity normalization29 Jan 2026US 2026/0027189 A1Orpro Therapeutics, Inc.
- Vectors expressing methionine sulfoxide reductase (msr)4 Sep 2025US 2025/0276094 A1University of South Florida
- Dgat1/2-independent enzyme synthesizing storage lipids (diesl)9 Jan 2025US 2025/0011734 A1Stichting Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
- Fluorescent protein sensor capable of quantitatively measuring oxidation degree of methionine residues of specific protein, and use thereof23 Nov 2023US 2023/0375562 A1Geronmed, Co. Ltd
- Biocatalyst as a core component of an enzyme-catalyzed redox system for the biocatalytic reduction of cystine20 Apr 2023US 2023/0124898 A1Wacker Chemie AG
Most cited
By later US patents
- Product and process for liquefaction of mucus or sputum12US 7,195,766 B2National Jewish Medical and Research Center · 2007
- Polynucleotides encoding BREX system polypeptides and methods of using same10US 10,767,156 B2Yeda Research and Development Co. Ltd. · 2020
- Ultrapurified DsbA and DsbC and methods of making and using the same7US 10,073,098 B2Genentech, Inc. · 2018
- Product and process for liquefaction of mucus or sputum7US 7,534,438 B2National Jewish Health · 2009
- Product and process for liquefaction of mucus or sputum4US 8,735,343 B2National Jewish Health · 2014